Early Detection of Cardiac Affection in Patients of Wilson's Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
Wilson disease (WD) is a rare autosomal recessive disorder caused by a genetic defect in ATP7B resulting in limited excretion of excess copper into the bile Pathological copper accumulation occurs in the entire body, with the liver and the brain being primarily affected
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients diagnosed with Wilson's
Disqualifiers
Claustrophobia
Refusal to share information
Heart failure
Trial population
All patients with Wilson's disease attending outpatient clinic
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
evaluate spectrum of cardiac affection by copper deposition in Wilson disease patients and detect early cardiac affection
Evaluate the effect of copper on EF and diastolic function of LV and RV
Time frame
1 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: